Medpace Holdings, Inc. Earnings

Medpace Holdings, Inc.’s revenue jumped 9.3% since last year same period to $558.57Mn in the Q1 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated 4.1% jump in its revenue since last 3-months.

Medpace Holdings, Inc.’s net profit jumped 11.7% since last year same period to $114.6Mn in the Q1 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated -2.07% fall in its net profits since last 3-months.

Medpace Holdings, Inc.’s net profit margin jumped 2.2% since last year same period to 20.52% in the Q1 2025. On a quarterly growth basis, Medpace Holdings, Inc. has generated -5.92% fall in its net profit margins since last 3-months.

Medpace Holdings, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 24.56.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.99 - a -2.84% fall from last quarter’s estimates.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 2.99.

Medpace Holdings, Inc.’s earning per share (EPS) jumped 14.69% since last year same period to 3.67 in the Q1 2025. This indicates that the Medpace Holdings, Inc. has generated 14.69% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Medpace Holdings, Inc.’s return on assets (ROA) stands at 0.15.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Medpace Holdings, Inc.’s return on equity (ROE) stands at 0.66.